Heron scoops approval for IV postoperative nausea treatment Heron scoops approval for IV postoperative nausea treatment 24-Oct-2022 By Ben Hargreaves Heron Therapeutics receives approval for its intravenous (IV) injection version of aprepitant, which had previously only been delivered orally.